BRIEF published on 11/06/2024 at 14:30, 14 days 23 hours ago IMMOFINANZ Secures Green Loan for Warsaw Spire Real Estate IMMOFINANZ Sustainable Finance Green Loan Warsaw Spire
PRESS RELEASE published on 11/06/2024 at 14:25, 14 days 23 hours ago IMMOFINANZ signs Green Loan for Warsaw Spire IMMOFINANZ secures EUR 180 million green loan for Warsaw Spire, replacing previous financing. Loan provided by Helaba, pbb Deutsche Pfandbriefbank, and Berlin Hyp Real Estate Financing IMMOFINANZ Green Loan Warsaw Spire
BRIEF published on 09/25/2024 at 20:11, 1 month 25 days ago IMMOFINANZ Increases Shareholding in S IMMO to 89% Acquisition Real Estate Shareholding IMMOFINANZ S IMMO
PRESS RELEASE published on 09/25/2024 at 20:06, 1 month 25 days ago IMMOFINANZ increases shareholding in S IMMO to 89% IMMOFINANZ increases shareholding in S IMMO to 89% by acquiring shares from CPI Property Group. The purchase price is EUR 608.5 million. Transaction agreements signed on September 25, 2024 Acquisition CPI Property Group Shareholding IMMOFINANZ S IMMO
BRIEF published on 09/04/2024 at 16:05, 2 months 16 days ago IMMOFINANZ Initiates Negotiations to Acquire CPIPG’s Remaining Stake in S IMMO Acquisition Real Estate IMMOFINANZ S IMMO CPIPG
PRESS RELEASE published on 09/04/2024 at 16:00, 2 months 16 days ago EQS-Adhoc: IMMOFINANZ AG: IMMOFINANZ starts negotiations to purchase CPIPG’s remaining 38.37%-stake in S IMMO IMMOFINANZ AG starts negotiations to purchase CPIPG's remaining stake in S IMMO. The potential transaction would make IMMOFINANZ 100% shareholder of S IMMO Acquisition Negotiations IMMOFINANZ S IMMO CPIPG
BRIEF published on 09/03/2024 at 18:26, 2 months 17 days ago IMMOFINANZ: Executive Board Appointment of Pavel Měchura Extended Real Estate Executive Board Corporate News IMMOFINANZ Pavel Měchura
PRESS RELEASE published on 09/03/2024 at 18:21, 2 months 17 days ago IMMOFINANZ: Executive Board appointment of Pavel Měchura extended IMMOFINANZ extends Pavel Měchura's Executive Board appointment until 30 April 2027. Supervisory Board ensures continuity in leadership for successful development Real Estate Executive Board Supervisory Board IMMOFINANZ Pavel Měchura
BRIEF published on 09/03/2024 at 16:53, 2 months 17 days ago IMMOFINANZ AG Sets Cash Compensation for S IMMO AG's Minority Shareholders at EUR 22.05 per Share S IMMO AG IMMOFINANZ Squeeze-out Cash Compensation Valuation Report
PRESS RELEASE published on 09/03/2024 at 16:48, 2 months 17 days ago EQS-Adhoc: IMMOFINANZ AG: Cash compensation for S IMMO AG's minority shareholders set to EUR 22.05 per share IMMOFINANZ AG sets cash compensation for S IMMO AG's minority shareholders at EUR 22.05 per share in squeeze-out proceedings Minority Shareholders Cash Compensation IMMOFINANZ AG Squeeze-out Proceedings EUR 22.05 Per Share
Published on 11/21/2024 at 14:00, 19 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 19 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 19 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 49 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 43 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 4 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 59 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 34 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 34 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
